<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H82815077B6C64DCAAFDC19012224FAE2" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 206 IH: Healthy Technology Act of 2023</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-01-09</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 206</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230109">January 9, 2023</action-date><action-desc><sponsor name-id="S001183">Mr. Schweikert</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.</official-title></form><legis-body id="H98373396F7A44B5F9647F5F7258CEB4B" style="OLC"> 
<section id="HCF4B6A38DFD241D2A1BB2B37C2AC0F3A" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Healthy Technology Act of 2023</short-title></quote>.</text></section> <section id="H76633E1A9A11427897FFC9C3AE4BA3B3"><enum>2.</enum><header>Prescription of drugs by artificial intelligence or machine learning technologies</header><text display-inline="no-display-inline">Section 503(b) of Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/353">21 U.S.C. 353(b)</external-xref>) is amended by adding at the end the following:</text>
<quoted-block style="OLC" id="H57B9A3F3D9FD4DE5B229A395B68FF130" display-inline="no-display-inline">
<paragraph id="H4FB413F879074CA7929A25132280F81A" indent="up1"><enum>(6)</enum><text display-inline="yes-display-inline">In this subsection, the term <term>practitioner licensed by law to administer such drug</term> includes artificial intelligence and machine learning technology that areâ€”</text> <subparagraph id="HDF2D15478E264616B25552F7CBC663DF"><enum>(A)</enum><text display-inline="yes-display-inline">authorized pursuant to a statute of the State involved to prescribe the drug involved; and</text></subparagraph>
<subparagraph id="H338EFF48A1724EE699DA73CFBAD2A6BD"><enum>(B)</enum><text display-inline="yes-display-inline">approved, cleared, or authorized under section 510(k), 513, 515, or 564.</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></section> </legis-body></bill>

